These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 18390638)

  • 1. In vivo three-dimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm.
    de Bruin DM; Burnes DL; Loewenstein J; Chen Y; Chang S; Chen TC; Esmaili DD; de Boer JF
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4545-52. PubMed ID: 18390638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab.
    Sayanagi K; Sharma S; Yamamoto T; Kaiser PK
    Ophthalmology; 2009 May; 116(5):947-55. PubMed ID: 19232732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
    Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
    Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization.
    Khurana RN; Dupas B; Bressler NM
    Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on choroidal neovascularization after anti-VEGF Upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography.
    Framme C; Panagakis G; Birngruber R
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1671-6. PubMed ID: 19875667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration.
    Malamos P; Sacu S; Georgopoulos M; Kiss C; Pruente C; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4926-33. PubMed ID: 19494200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration.
    Coscas F; Coscas G; Souied E; Tick S; Soubrane G
    Am J Ophthalmol; 2007 Oct; 144(4):592-9. PubMed ID: 17698019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd.
    Keane PA; Chang KT; Liakopoulos S; Jivrajka RV; Walsh AC; Sadda SR
    Retina; 2009 May; 29(5):592-600. PubMed ID: 19289984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease.
    Ahlers C; Golbaz I; Einwallner E; Dunavölgyi R; Malamos P; Stock G; Pruente C; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3417-24. PubMed ID: 19168899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration.
    Sayanagi K; Sharma S; Kaiser PK
    Br J Ophthalmol; 2009 May; 93(5):622-6. PubMed ID: 19208677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by high-penetration optical coherence tomography.
    Yasuno Y; Miura M; Kawana K; Makita S; Sato M; Okamoto F; Yamanari M; Iwasaki T; Yatagai T; Oshika T
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):405-13. PubMed ID: 18676629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomography.
    You JY; Chung H; Kim HC
    Curr Eye Res; 2012 May; 37(5):438-45. PubMed ID: 22510011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography.
    Ahlers C; Simader C; Geitzenauer W; Stock G; Stetson P; Dastmalchi S; Schmidt-Erfurth U
    Br J Ophthalmol; 2008 Feb; 92(2):197-203. PubMed ID: 17965102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study.
    Do DV; Gower EW; Cassard SD; Boyer D; Bressler NM; Bressler SB; Heier JS; Jefferys JL; Singerman LJ; Solomon SD
    Ophthalmology; 2012 Apr; 119(4):771-8. PubMed ID: 22297028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
    Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T
    Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
    Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G
    Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies.
    Stopa M; Bower BA; Davies E; Izatt JA; Toth CA
    Retina; 2008 Feb; 28(2):298-308. PubMed ID: 18301035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration.
    Ahlers C; Golbaz I; Stock G; Fous A; Kolar S; Pruente C; Schmidt-Erfurth U
    Ophthalmology; 2008 Aug; 115(8):e39-46. PubMed ID: 18675694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
    Carvounis PE; Kopel AC; Benz MS
    Am J Ophthalmol; 2007 Mar; 143(3):504-5. PubMed ID: 17317395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.